Tizanidine Hydrochloride Capsule
Product Images NDC 71335-2559

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 71335-2559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352559)

Each capsule of this medication contains 4.58 mg of tizanidine hydrochloride, which is equivalent to 4 mg of tizanidine base. It is important to protect this product by storing it at 25°C (77°F) and dispensing it in containers with child-resistant closures. This information should be referenced along with the package insert QR code for prescribing details. Additionally, it is advised to keep this medication out of children's reach.*

FDA Label Image

Figure 1 (Tizanidine Hydrochloride Capsules Figure 1)

FDA Label Image

Figure 2 (Tizanidine Hydrochloride Capsules Figure 2)

This text includes information about two dosages of tizanidine (16 mg and 8 mg) and references to the improvement in Ashworth Score over time post-dose. The Ashworth Score is a measure used in assessing muscle spasticity. This document likely presents data regarding the effects of these dosages on muscle tone and spasticity post-administration.*

FDA Label Image

Figure 3 (Tizanidine Hydrochloride Capsules Figure 3)

This text provides information on the medication Tizanidine and its use in a study comparing its efficacy to a placebo. The study evaluates the improvement in Ashworth Score over time, with data points at the end of titration, the end of maintenance, and the final endpoint. The study lasted for 7 weeks, and the mean dose of Tizanidine used was 28.8 mg. The last observation carried forward method was employed for analysis.*

FDA Label Image

Chemical Structural Formula (Tizanidine Hydrochloride Capsules Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.